Introduction
One of the most relevant questions in the quantitative study of inborn errors of metabolism is how a given deficiency is expressed in the flux through metabolic pathways. Some partial answers are available: first, the range of enzyme activities in the normal human population is rather large suggesting that wide variations in enzyme activities do not greatly affect the metabolic fluxes; secondly, most of the genetically characterized metabolic diseases appear to be recessive, that is, they are not expressed in heterozygotes, but require the presence of two copies of the mutated genes. In approximate terms this means that 50% of the normal amount of a given enzyme is enough to sustain a normal activity of metabolism. This greatly puzzled the first authors of the synthetic theory of evolution (reviewed in [l]); thirdly, the recent discoveries of pathological mitochondrial DNA (mtDNA) mutations in mitochondrial diseases have thrown a new light on the problem of the expression of mutations in metabolism because of the peculiarities of mitochondrial genetics. From a quantitative point of view, the main result of all these observations is that the mutations are (fortunately) not proportionately expressed in metabolism. We will show that metabolic control analysis [2-41 (and reviewed in [5] ) allows a simple and logical explanation of this behaviour.
Threshold in the expression of mitochondrial mutations
One of the most important salient features in mitochondrial genetics is that there are thousands of copies of the mtDNA in a single cell, since each cell contains hundreds of mitochondria and each mitochondrion contains 2-10 copies of the mtDNA [6]. This contrasts with nucleus-encoded genes for which only two copies exist. Mutations of the mitochondrial genome do not usually affect all of the mtDNA, but only a variable fraction of the mtDNA molecules. The coexistence of both mutant and normal mtDNA Abbreviation used: mtDNA, mitochondrial DNA. 'To whom correspondence should be addressed. molecules in a mitochondrion, a cell or a tissue is called heteroplasmy (i.e. heteroplasmy of mtDNA). Because of the large number of mtDNA molecules one can understand that the degree of heteroplasmy can vary quasi-continuously between 0 and 100% and is not necessarily the same in all tissues. The main question in the study of mitochondrial diseases caused by mtDNA mutations is how the degree of heteroplasmy is expressed in the two relevant mitochondrial fluxes: the respiratory rate and the rate of ATP synthesis.
As a matter of fact, the answer is known: Chomyn et al. [7] has shown that in the case of the 3243 mutation in MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like episodes), lo%, or perhaps less, of wild-type DNA is sufficient to sustain a normal respiratory rate. Other authors had already shown, or have recently confirmed, that in the case of other tRNA mutations or in the case of deletions, 10% of wild-type mtDNA is usually enough to observe normal activity. (For instance Sciacco et al. [8] showed that '85-90% deleted mitochondrial DNA must be reached before cytochromec-oxidase activity is impaired'. The phenotypic expression of tRNA mutations is complex because they affect all of the mitochondrially encoded subunits, although differentially according to their amino-acid composition. An example of an effect on a single complex was given by Bindoff and Turnbull [9]; they observed that in both a patient with cytochrome c oxidase deficiency and in an animal model, (a copper-deficient rat) lowering the activity of complex IV by over 50% did not affect the respiratory flux. More recently, Kuznetsov et al. [lo] have shown that in a mouse mutant with a severe copper deficiency the activity of cytochrome-c-oxidase is only about 50% of the normal activity, but that no difference was found in maximal rates of respiration; however, the control coefficient (see later) was higher in the mutants (0.8 instead of 0.30 for the control value).
All of these studies demonstrate clearly that there is a threshold in the heteroplasmy of the mutation of around 90%. Above this threshold,
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when there is more than 90% of the mutation, the mutation leads to pathological behaviour.
We have demonstrated that the use of specific inhibitors is another way to mimic a deficiency of a respiratory complex [ 11-131. Figure  1A shows the effect of rotenone on complex I activity alone and on the rate of oxygen consumption at the same concentrations of rotenone. It can be seen that, even at 50% inhibition of complex I, only a very weak inhibition of the flux through the whole chain is observed and that complex I inhibition needs to be 80% or more to obtain a substantial inhibition of respiration. This effect is more obvious when it is represented as in Figure 1B where the inhibition of the respiratory flux is plotted as a function of the complex I inhibition for the same rotenone concentrations. A clear-cut threshold is observed: until 70% inhibition of complex I, the respiratory rate decreases slowly, but beyond 70% of complex I inhibition, the respiratory rate decreases abruptly to zero. The same pattern is observed in inhibition of other complexes [11, 12] . A similar approach has also been presented in [14] .
The explanation of the threshold effect in the framework of metabolic control analysis
We have already interpreted the behaviour shown in Figure 1 in the framework of metabolic control theory [13] . In this theory an important parameter is defined: the control coefficient which expresses quantitatively the effect on a flux of a perturbation of a step. For instance a control coefficient of 0.1 for complex I means that a 1% decrease in the activity of this complex will only entail a 0.1% decrease in the respiration rate. Thus, this parameter is perfectly suited to account for the flux consequences of inborn errors of metabolism. The value of control coefficient appears clearly as the initial slope of the curve in Figure 1B .
A very important consequence of the definition of control coefficient is the summation theorem, stating that in a metabolic network, the sum of the flux control coefficients of every step of the network on any given flux is equal to one: The summation theorem has several important consequences: the control of a pathway can be shared among various steps in proportion to their control coefficient. There is not necessarily, and not generally, a single limiting step in a pathway; the distribution of the control can change. This point is particularly relevant in the Volume 26 case of metabolic diseases in which steady-state fluxes are changed; because most of the control coefficients are between 0 and 1, and because their sum is 1, most of them have to be small. Although one can find counter-examples to this proposition [ 171 the experimental determination of control coefficients demonstrates the widespread occurrence of low values of control coefficients. We will show that the shape of Figure 1B is the inescapable consequence of small control coefficient values. The value of the control coefficient is the slope of the tangent to the initial part of the curve, of the flux as a consequence of changes in the step.
At the beginning (a small deficit due to the low rotenone concentration), a quasi-horizontal slope is observed due to the low control coefficient. On the contrary, at a very low activity of the step (high rotenone concentration) both curves must meet again, due to the fact that the flux becomes zero when the step is being completely inactivated. This behaviour leads to a sigmoid-shaped flux-inhibition curve and thus to a threshold when the flux is plotted as a function of the inhibition of one of its steps.
Variation of the threshold values with tissue type and energetic demand
We have seen that expression of a defect exhibits a threshold below which no effect is observed. This threshold depends upon the control coefficient (in the normal organism) of the affected step. Because different tissues operate at different steady states, with different amounts and sometimes types (isoforms) of enzymes, neither the control coefficient of a step nor the threshold are generally the same in different tissues, so that the same given deficiency can affect one tissue (above the threshold for this tissue) and not another (below the threshold). This is encountered particularly in mitochondrial diseases where this phenomenon can be reinforced by different degrees of heteroplasmy. Table 1 summarizes the control coefficient values of complex I and its corresponding threshold values in muscle, heart, liver, kidney and brain: the lower the control coefficient, the higher the threshold.
In the case of mitochondrial diseases, another parameter can affect the threshold values. This is the energetic demand of the cell. This point has been studied theoretically in our laboraory and can be appreciated in Figure 2 . At low energetic load (low cytosolic ATP consumption) a high threshold value is observed because the mitochondria have a high capacity to respond. At higher energetic demand the threshold value decreases to zero when the mitochondria just supply the demand. This is an additional explanation for the tissue specificity observed in these pathologies. This is also an explanation for the cases in which the pathology state is revealed by particular conditions increasing the demand. This seems to be the case in the P-oxidation of fatty acids in fasting states since, under these circumstances, this pathway is the principal source of ATP in some tissues such as liver and heart. Thus, fasting can reveal a deficiency in P-oxidation that was not apparent in normal functioning. This could also be the case of Reye's syndrome induced by aspirin.
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Other examples Kacser and Burns [l] were probably the first to emphasize that the recessivity in Mendelian mutations, 'far from constituting a problem requiring an evolutionary explanation' was an inescapable consequence of the summation theorem, owing to the buffering effect of intermediate metabolites. The summation theorem eliminates the necessity to invoke natural selection to explain such a behaviour. It nevertheless has evolutionary implications: demonstrating that most enzyme variations will have a weak effect on metabolism, it reinforces the idea that most gene mutations should appear as neutral.
In their first paper [2], Kacser and Burns also gave the first examples of threshold in the expression of various degrees of mutations in different steps of the arginine pathway in Neurospora crassa. They showed that the percentage of the wild-type activity has to be less than 25% in order to observe an appreciable diminution of the flux (see also [18, 19] ). More recently we described the same behaviour in the case of carnitine-palmityl transferase I1 (CPTII) deficiency [19a] . We studied the oxidative flux of a long chain fatty acid (myristic acid) as a function of CPTII activity in skin fibroblasts. In the heterozygote parents the CPTII activity is approximately 50% of the normal activity, and the flux is virtually unchanged (the parents are not clinically affected). In some patients, although the residual activity is around 20%, the oxidative flux is not lowered much and the clinical signs, exclusively in muscles, only appear when the demand for fatty acids is markedly increased (prolonged musclar exercise). When the residual activity of CPTII is below 10% serious clinical hepatic signs appear (e.g. hypoglycaemia after fasting) and the fatty ngure 2
Theoretical flux as a function of a complex deficiency (inhibition) under different conditions of ATP utilization
According to the model development in [22] . 
Conclusion
Several mutations of mtDNA have been described recently that can lead to different pathologies as a function of the heteroplasmy of the mutation in the various tissues. One of the main salient features recognized in mitochondrial diseases is the existence of a threshold in the expression of the disease as a function of the mitochondrial deficit. The value of the threshold can be very high, around 90%. This means that 10% of activity is enough to sustain a quasinormal mitochondrial oxidative phosphorylating flux.
The value of the threshold is dependent upon the control coefficient value of the deficient step but also of the energy demand of the cell (Figure 2 ). This explains why different tissues, housing different type of mitochondria (with different control coefficients), working at different steady-state levels and supplying different energy demands can express mitochondrial deficiencies differently [ZO] . As a matter of fact this result, though clearly apparent in mitochondria because the heteroplasmy phenomenon allows a complete range of variation of a mutation between 0 and loo%, is more general and had already been approached particularly by Kacser & Burns [l] . Metabolism is very tolerant towards enzyme deficiencies, due to the buffering power of metabolite intermediates. We show here (see also [14, 21] ) that it is an inescapable and fortunate consequence of the systemic properties of metabolic pathways as revealed by metabolic control analysis and more particularly by the summation theorem. 
Recent developments in the detection

